303 related articles for article (PubMed ID: 1796753)
1. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
Bouillon R; Allewaert K; Xiang DZ; Tan BK; van Baelen H
J Bone Miner Res; 1991 Oct; 6(10):1051-7. PubMed ID: 1796753
[TBL] [Abstract][Full Text] [Related]
2. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3.
Bouillon R; Sarandeses LA; Allewaert K; Zhao J; MascareƱas JL; MouriƱo A; Vrielynck S; de Clercq P; Vandewalle M
J Bone Miner Res; 1993 Aug; 8(8):1009-15. PubMed ID: 8213251
[TBL] [Abstract][Full Text] [Related]
3. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
4. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
[TBL] [Abstract][Full Text] [Related]
5. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.
Swamy N; Dutta A; Ray R
Biochemistry; 1997 Jun; 36(24):7432-6. PubMed ID: 9200691
[TBL] [Abstract][Full Text] [Related]
6. Regulation of calbindin-D28K gene expression in the chick intestine: effects of serum calcium status and 1,25-dihydroxyvitamin D3.
Hall AK; Norman AW
J Bone Miner Res; 1990 Apr; 5(4):331-6. PubMed ID: 1693035
[TBL] [Abstract][Full Text] [Related]
7. Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs.
Bishop JE; Collins ED; Okamura WH; Norman AW
J Bone Miner Res; 1994 Aug; 9(8):1277-88. PubMed ID: 7976510
[TBL] [Abstract][Full Text] [Related]
8. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1,25,28-trihydroxyvitamin D2 and 1,24,25-trihydroxyvitamin D3 on intestinal calbindin-D9K mRNA and protein: is there a correlation with intestinal calcium transport?
Wang YZ; Li H; Bruns ME; Uskokovic M; Truitt GA; Horst R; Reinhardt T; Christakos S
J Bone Miner Res; 1993 Dec; 8(12):1483-90. PubMed ID: 8304050
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
[TBL] [Abstract][Full Text] [Related]
11. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. On the mechanisms for the selective action of vitamin D analogs.
Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
[TBL] [Abstract][Full Text] [Related]
14. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
15. 1 alpha,25-(OH)2-vitamin D3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro.
Fleet JC; Bradley J; Reddy GS; Ray R; Wood RJ
Arch Biochem Biophys; 1996 May; 329(2):228-34. PubMed ID: 8638956
[TBL] [Abstract][Full Text] [Related]
16. Conformationally restricted analogs of 1 alpha, 25-dihydroxyvitamin D3 and its 20-epimer: compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor.
Yamamoto K; Sun WY; Ohta M; Hamada K; DeLuca HF; Yamada S
J Med Chem; 1996 Jul; 39(14):2727-37. PubMed ID: 8709103
[TBL] [Abstract][Full Text] [Related]
17. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
18. Actions of calcipotriol (MC 903), a novel vitamin D3 analog, on human bone-derived cells: comparison with 1,25-dihydroxyvitamin D3.
Evans DB; Thavarajah M; Binderup L; Kanis JA
J Bone Miner Res; 1991 Dec; 6(12):1307-15. PubMed ID: 1792941
[TBL] [Abstract][Full Text] [Related]
19. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin).
Hinek A; Poole AR
J Bone Miner Res; 1988 Aug; 3(4):421-9. PubMed ID: 3265578
[TBL] [Abstract][Full Text] [Related]
20. Regulation of calbindin-D28K gene expression by 1,25-dihydroxyvitamin D3 in chick kidney.
Hall AK; Norman AW
J Bone Miner Res; 1990 Apr; 5(4):325-30. PubMed ID: 1693034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]